Often characterized by involuntary motor or vocal tics, Tourette syndrome typically appears in childhood and affects up to ...
DeAndre Hopkins moved from one two-time MVP quarterback to another. After reaching the Super Bowl last season with Patrick ...
Bird flu. With that diagnosis in mind, one of Russo’s colleagues tried to get some bovine samples tested for H5N1, but the ...
Digital distractions, endless entertainment and convenience culture shape behavior, making true engagement with creativity, ...
PharmNovo conducted a regulatory pre-IND Type B meeting with the FDA in January 2025. Such meetings are typically held before submitting an Investigational New Drug (IND) application, which is ...
OKYO Pharma Limited (NASDAQ:OKYO ), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA ...
HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...
Learn more about eLife assessments Sleep disturbances are associated with poor long-term memory (LTM) formation, yet the underlying cell types and neural circuits involved have not been fully decoded.
Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...
Kidney stones are among the possible risks of GLP-1 use that were not previously known. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) may have a wider range of benefits and risks than what the ...